Skip to main content
Caplight Logo









FineHeart

FineHeart

Private
PessacHealthcare & Life Scienceshttps://fineheart.fr/

Last Round

Series C

Jan 9, 2026

Total Funding Raised

$75.41M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

FineHeart is a medical device company that develops the FLOWMAKER®, a wirelessly powered, fully implantable mechanical circulatory support device for patients with severe heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

ICOMS FLOWMAKERheart failure deviceimplantable cardiac deviceheart pumpcardiac output acceleratorsevere heart failureLVAD alternativedriveline-freewireless rechargingMedTechminimally invasive procedureLeft Ventricular Assist DeviceLVADbeating-heart surgerytranscutaneous energy transferImplantable Cardiac Output Management SystemICOMSclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FineHeart Comparables

Compare FineHeart with similar companies based on industry and business-model similarity.

FineHeart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CorWave
91%
BrioHealth Solutions
81%
Puzzle Medical Devices Inc.
79%

FineHeart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJan 9, 2026
GrantOct 19, 2022
Series B ExtensionDec 15, 2021
Series BJun 1, 2021
Series AMar 21, 2016

Key People

Founding team and executive leadership

arnaud Mascarell

Chief Executive Officer and co-founder

Founding Team

Guillaume Buc

CTO, FineHeart

Executive Team

Sebastien Robitaille

CFO

Executive Team

FineHeart Investors

Notable investors and investment history

FineHeart investors
InvestorRounds
European Innovation Council FundSeries C
Verve VenturesSeries B Extension, Series B
European CommissionGrant
Verve CapitalSeries C
Aqui-InvestSeries A
Groupe Pasteur MutualitéSeries C
UI InvestmentSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Open roles increased to 49, 5.2x the trailing average.

  • Feb 1, 2026

    Monthly visitors grew 191% MoM, reaching 2.6K.

FineHeart Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FineHeart Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FineHeart's valuation, stock price, and market status.

Firmographic Details

HeadquartersPessac
Employee Range87
Year Founded2010
Last FundingJan 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?